CN103288760B - 卡奈替尼的制备方法 - Google Patents
卡奈替尼的制备方法 Download PDFInfo
- Publication number
- CN103288760B CN103288760B CN201310180884.9A CN201310180884A CN103288760B CN 103288760 B CN103288760 B CN 103288760B CN 201310180884 A CN201310180884 A CN 201310180884A CN 103288760 B CN103288760 B CN 103288760B
- Authority
- CN
- China
- Prior art keywords
- chloro
- morpholinyl
- quinazoline
- preparation
- propoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310180884.9A CN103288760B (zh) | 2013-05-16 | 2013-05-16 | 卡奈替尼的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310180884.9A CN103288760B (zh) | 2013-05-16 | 2013-05-16 | 卡奈替尼的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103288760A CN103288760A (zh) | 2013-09-11 |
CN103288760B true CN103288760B (zh) | 2015-02-18 |
Family
ID=49090348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310180884.9A Expired - Fee Related CN103288760B (zh) | 2013-05-16 | 2013-05-16 | 卡奈替尼的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103288760B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066099A2 (en) * | 2000-03-06 | 2001-09-13 | Astrazeneca Ab | Use of quinazoline derivatives as angiogenesis inhibitors |
WO2002000644A1 (en) * | 2000-06-24 | 2002-01-03 | Astrazeneca Ab | Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
CN1633431A (zh) * | 2000-08-18 | 2005-06-29 | 千年药物股份有限公司 | 喹唑啉衍生物类激酶抑制剂 |
CN101341133A (zh) * | 2005-12-22 | 2009-01-07 | 阿斯利康(瑞典)有限公司 | 喹唑啉衍生物,其制备方法及其作为抗癌药的用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2242493B1 (en) * | 2008-01-22 | 2013-06-05 | Concert Pharmaceuticals Inc. | Derivatives of gefitinib |
US20100143295A1 (en) * | 2008-12-05 | 2010-06-10 | Auspex Pharmaceuticals, Inc. | Quinazoline inhibitors of egfr tyrosine kinase |
-
2013
- 2013-05-16 CN CN201310180884.9A patent/CN103288760B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066099A2 (en) * | 2000-03-06 | 2001-09-13 | Astrazeneca Ab | Use of quinazoline derivatives as angiogenesis inhibitors |
WO2002000644A1 (en) * | 2000-06-24 | 2002-01-03 | Astrazeneca Ab | Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
CN1633431A (zh) * | 2000-08-18 | 2005-06-29 | 千年药物股份有限公司 | 喹唑啉衍生物类激酶抑制剂 |
CN101341133A (zh) * | 2005-12-22 | 2009-01-07 | 阿斯利康(瑞典)有限公司 | 喹唑啉衍生物,其制备方法及其作为抗癌药的用途 |
Non-Patent Citations (1)
Title |
---|
卡奈替尼的合成工艺改进;刘剑峰等;《齐鲁药事》;20111231;第30卷(第10期);559-561 * |
Also Published As
Publication number | Publication date |
---|---|
CN103288760A (zh) | 2013-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009313970A1 (en) | Methods of preparing quinoline derivatives | |
CN103242303B (zh) | 阿法替尼的制备方法 | |
CN105418483A (zh) | 一种结晶型乙磺酸尼达尼布的制备方法 | |
CN106279104B (zh) | 一种制备琥珀酸曲格列汀的工艺改进方法 | |
CN103601686A (zh) | 一锅法合成含氟的嘧啶类化合物的方法 | |
CN101973944A (zh) | 一种Gefitinib Form 1晶型新的制备方法 | |
CN105198821A (zh) | 洛昔替尼的制备方法 | |
CN105218445B (zh) | 一种酪氨酸激酶抑制剂Foretinib的制备方法 | |
CN109456329A (zh) | 一种泛昔洛韦的制备方法 | |
CN103288760B (zh) | 卡奈替尼的制备方法 | |
CN107759596A (zh) | 一种合成帕博西尼的方法 | |
CN104876865A (zh) | 一种博舒替尼的制备工艺 | |
CN103145636A (zh) | 一种1,4-二酰基-3,6-二苯基-1,4-二氢均四嗪类化合物及其制备方法和应用 | |
CN100537563C (zh) | N-苯基-2-嘧啶胺衍生物的制备方法 | |
CN103254156B (zh) | 阿法替尼中间体的制备方法 | |
CN102382100B (zh) | 伊马替尼的制备方法 | |
CN103242244B (zh) | 一种卡奈替尼的制备方法 | |
CN104649966A (zh) | 一种有机中间体5-氰基-3甲基吡啶甲酸的合成方法 | |
CN109988108A (zh) | 一种卡博替尼的制备方法 | |
CN103265497B (zh) | 一种替尼类抗肿瘤药合成所需中间体4-氯-6-氨基-7-羟基喹唑啉及其制备方法 | |
CN104109135A (zh) | 1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪的制备方法 | |
CN103288759B (zh) | 达克米替尼的制备方法 | |
CN103373954B (zh) | 一种1-苄基-4-甲氧甲基-4-苯胺基哌啶盐酸盐的制备方法 | |
CN102718720B (zh) | 4-[(4,6-二氯-2-嘧啶基)氨基]苯腈的制备方法 | |
CN101935317B (zh) | 2-甲基-7-(取代嘧啶-4-氨基)-4-(取代哌啶-1-基)异吲哚啉-1-酮及中间体的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181206 Address after: 214425 No. 23 Huanxi Road, Zhutang Town, Jiangyin City, Jiangsu Province Patentee after: JIANGSU ADOPTION MEDICAL TECHNOLOGY CO., LTD. Address before: Room 1305, 1 Building, Lianfeng Commercial Plaza, Suzhou Industrial Park, Jiangsu Province Co-patentee before: Xu Xuenong Patentee before: Suzhou Mingyue Medical Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200409 Address after: 236200 Anhui province Fuyang City Yingshang Industrial Development Zone Patentee after: ANHUI GOLDEN SUN BIOPHARMACEUTICALS Co.,Ltd. Address before: 214425 No. 23 Huanxi Road, Zhutang Town, Jiangyin City, Jiangsu Province Patentee before: Jiangsu Caina Medical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150218 Termination date: 20200516 |
|
CF01 | Termination of patent right due to non-payment of annual fee |